Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy

@article{Silverman2006AlteredFC,
  title={Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy},
  author={Daniel H. S. Silverman and Christine Dy and Steven A. Castellon and Jasmine Lai and Betty S. Pio and Laura Abraham and Kari Waddell and Laura Petersen and Michael E. Phelps and Patricia A. Ganz},
  journal={Breast Cancer Research and Treatment},
  year={2006},
  volume={103},
  pages={303-311}
}
Purpose To explore the relationship of regional cerebral blood flow and metabolism with cognitive function and past exposure to chemotherapy for breast cancer.Patients and methods Subjects treated for breast cancer with adjuvant chemotherapy remotely (5–10 years previously) were studied with neuropsychologic testing and positron emission tomography (PET), and were compared with control subjects who had never received chemotherapy. [O-15] water PET scans was acquired during performance of… 
The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.
  • B. Baudino, F. D’Agata, G. Bisi
  • Psychology, Medicine
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
  • 2012
TLDR
Investigating the neural basis of the chemotherapy induced neurobehavioral changes by means of metabolic imaging and neuropsychological testing concluded that the mechanism could be an accelerating ageing / oxidative stress that, in some patients at risk, could result in an early and persistent cognitive impairment.
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer
TLDR
Results indicate that high‐dose adjuvant chemotherapy is associated with long‐term cognitive impairments, underpinned by task‐specific hyporesponsiveness of dorsolateral prefrontal cortex and parahippocampal gyrus and a generalized hyporeSponsiveness of lateral posterior parietal cortex encompassing attentional processing.
Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations
TLDR
A review of currently available published observations of cognitive effects of cancer and its treatment discusses the major themes and promising directions for future studies.
A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy
TLDR
The aim of this paper was to survey the reports on cerebral structural and functional alterations in women with breast cancer treated with chemotherapy (CTx), and focuses on compensatory mechanisms, which activate additional brain areas or neural connection to reach the premorbid cognitive efficiency.
Neural Correlates and Functional Cognitive Maps in Breast Cancer Survivors Receiving Different Chemotherapy Regimens; a QEEG/HEG-based Investigation
TLDR
Increased cognitive workload and lack of cognitive ease in breast cancer patients treated with the AC-T regimen is revealed, proposing the presumable neurotoxic sequelae of this chemotherapy regimen in comparison with the TAC regimen.
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type
TLDR
Parietal hyperactivation after systemic treatment in the context of stable levels of executive task performance is compatible with a compensatory processing account of hyperactivation or maintain adequate performance levels, suggesting different neurobehavioral trajectories in breast cancer patients depending on treatment type.
Cerebral Blood Flow and its Connectivity Deficits in Patients With Lung Cancer After Chemotherapy
TLDR
Findings indicated that chemotherapy is associated with abnormalities in the CBF and connectivity alterations, which may contribute to the cognitive impairment in patients with lung cancer.
Chemotherapy effects on brain glucose metabolism at rest
TLDR
The present study shows that chemotherapy induces significant transient changes in the glucose metabolism of multiple cerebral cortical and white matter regions with a prevailing involvement of the prefrontal cortex, and the severity of these changes are significantly related with the number of chemotherapy cycles.
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage
TLDR
This is the first study to show structural and functional effects of PCI and to relate oxidativeDNA damage to brain alterations in BCS and the relationship with oxidative DNA damage provides a mechanistic clue warranting further investigation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 74 REFERENCES
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
TLDR
It is suggested that cognitive impairment may follow conventional adjuvant chemotherapy treatment and warrant replication with a controlled and more rigorous longitudinal design.
Molecular Imaging of Biological Processes with PET: Evaluating Biologic Bases of Cerebral Function
TLDR
Both research-oriented and clinically oriented applications of brain PET are highlighted, providing illustrations of how the power of this methodology to image and quantify neurobiologic parameters can impact upon the assessment of brain function and dysfunction.
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
TLDR
Examination of neurocognitive functioning among breast cancer survivors exposed to systemic adjuvant chemotherapy suggested that systemic chemotherapy, especially in combination with tamoxifen, can have adverse yet subtle effects on cognitive functioning.
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
TLDR
High-dose chemotherapy appears to impair cognitive functioning more than standard- dose chemotherapy, and central nervous system toxicity may be a dose-limiting factor in high-dose cancer treatment regimens.
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
  • T. Ahles, A. Saykin, P. Silberfarb
  • Medicine, Psychology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002
TLDR
Data from this study support the hypothesis that systemic chemotherapy can have a negative impact on cognitive functioning as measured by standardized neuropsychologic tests and self-report of memory changes and suggest that only a subgroup of survivors may experience long-term cognitive deficits associated with systemic chemotherapy.
Estrogen use and brain metabolic change in postmenopausal women
PET imaging in the assessment of normal and impaired cognitive function.
Cognitive function in breast cancer patients receiving adjuvant chemotherapy.
TLDR
Cognitive differences were observed in breast cancer patients receiving adjuvant chemotherapy compared with healthy controls, and these differences did not seem to be caused by significant differences in mood disturbance between the two groups.
...
1
2
3
4
5
...